Novacyt S.A.
NCYT.L · LSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | £35 | £43 | £80 | £261 |
| - Cash | £30 | £44 | £87 | £102 |
| + Debt | £12 | £14 | £1 | £2 |
| Enterprise Value | £16 | £13 | -£6 | £161 |
| Revenue | £20 | £12 | £21 | £96 |
| % Growth | 69.5% | -45% | -78% | – |
| Gross Profit | £32 | £4 | £6 | £30 |
| % Margin | 163.4% | 32.2% | 27.3% | 31% |
| EBITDA | -£34 | -£18 | -£12 | -£4 |
| % Margin | -174.8% | -157.6% | -55.5% | -4.4% |
| Net Income | -£42 | -£28 | -£22 | -£10 |
| % Margin | -212.7% | -244.3% | -105.5% | -10.2% |
| EPS Diluted | -0.59 | -0.4 | -0.31 | -0.14 |
| % Growth | -47.5% | -29% | -121.4% | – |
| Operating Cash Flow | -£9 | -£25 | -£14 | £16 |
| Capital Expenditures | -£2 | -£1 | -£0 | -£4 |
| Free Cash Flow | -£11 | -£26 | -£14 | £12 |